At Adelphi Values PROVE we recognise that value demonstration for orphan/ ultra-orphan drugs in rare diseases requires a different focus to support successful market access. Read More
Latest News
Find out what’s going on within Adelphi Values. Use the filters below to help find content more specific to your interests.
The Adelphi Values Patient-Centered Outcomes team are proud to share the news that the Novartis-sponsored MSProDiscuss™ tool has now gone live on-line (https://msprodiscuss.com) and is available for MS clinicians to use. This Clinician-Report discussion tool is available to help MS patients and physicians evaluate and… Read More
The Adelphi Values Patient-Centered Outcomes team are proud to share the news that the FDA have qualified the Asthma Daytime Symptom Diary (ADSD) and the Asthma Nighttime Symptom Diary (ANSD) as measures of the core symptoms of asthma in adults and adolescents. The FDA have highlighted that “these instruments have… Read More
We are delighted that one of our posters at ISPOR EU has been peer reviewed and nominated as an award finalist. The poster titled ‘Europe-wide spread of carbapenem-resistant bacteria: Epidemiology and disease burden’ provides an overview of antibiotic resistance, a critical global health issue which is becoming increasingly prevalent across Europe… Read More
The team at Adelphi Values | PROVE has been getting involved in environmentally-friendly initiatives in honour of World Earth Day which took place on Sunday 22nd April 2018. Read More
Each Christmas, instead of sending cards in the post, we at Adelphi Group provide our colleagues, partners and associates with the opportunity to nominate a worthy cause for us to donate to on their behalf.
In 2017, we supported Unicef to help make a difference for children all over the world. Read More
Adelphi Values applauds Revance Therapeutics in their demonstration of RT002 treatment success in their Pivotal SAKURA Phase 3 Trials for Glabellar Lines. Read More
Adelphi Values | PROVE will be leading a podium presentation entitled ‘Differences in vaccine pricing between high‑income and low‑income markets’. Read More
On Friday 28th July 2017 over 50 staff from the Adelphi Group took part in a 7 Peak Challenge – a marathon 26 mile walk through the Derbyshire and Cheshire hills located close to our UK head office. Despite the torrential rain and strong winds, everyone was proud to take part in the 9-hour hike to help raise money for two wonderful causes, The Alzheimer’s Society and East Cheshire Hospice. Read More
Adelphi Values will be presenting and exhibiting at the 22nd Annual International Meeting of ISPOR, the International Society of Pharmacoeconomics and Outcomes Research, which takes place from 20th‑24th May 2017 in Boston, MA, USA. Read More